Physician profile
Candis Lenette Broadnax
NPI 1740605781
$2,483.37
in general payments reported to CMS, 2019-2025
14 companies · $1,813 in 2025
The $1,813 reported for 2025 was more than what 91% of Adult Health (Clinical Nurse Specialist) providers received nationally (typical 2025 total: $186).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $232 · 2022: $185 · 2023: $172 · 2024: $80.49 · 2025: $1,813.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,111 · Travel and Lodging: $954.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,111.13 |
| Travel and Lodging | $954.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,729.93 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $382.70 | 2021-2025 | Lifevest |
| Amgen INC. | $70.25 | 2021-2023 | Repatha |
| Cvrx, INC. | $45.37 | 2024-2025 | Barostim Neo System |
| Abbott Laboratories | $41.21 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $35.14 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $33.65 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $32.57 | 2022 | |
| Arbor Pharmaceuticals, INC. | $24.94 | 2021 | |
| Novo Nordisk INC | $21.95 | 2023 | Ozempic |
| Kestra Medical Technology Services, INC. | $19.74 | 2025 | Assure Wcd |
| Surmodics, INC. | $15.86 | 2023 | Pounce Thrombectomy, Sublime Radial Access Guide Sheath, Sublime Radial Access 018 Rx Pta Dilatation Catheter |
| Boston Scientific Corporation | $15.15 | 2023 | Watchman Access System |
| Philips North America LLC | $14.91 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Candis Broadnax listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.